Literature DB >> 9811937

The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy.

P Burlet1, C Huber, S Bertrandy, M A Ludosky, I Zwaenepoel, O Clermont, J Roume, A L Delezoide, J Cartaud, A Munnich, S Lefebvre.   

Abstract

Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder characterized by degeneration of motor neurons of the spinal cord and muscular atrophy. SMA is caused by alterations to the survival of motor neuron (SMN) gene, the function of which has hitherto been unclear. Here, we present immunoblot analyses showing that normal SMN protein expression undergoes a marked decay in the postnatal period compared with fetal development. Morphological and immunohistochemical analyses of the SMN protein in human fetal tissues showed a general distribution in the cytoplasm, except in muscle cells, where SMN protein was immunolocalized to large cytoplasmic dot-like structures and was tightly associated with membrane-free heavy sedimenting complexes. These cytoplasmic structures were similar in size to gem. The SMN protein was markedly deficient in tissues derived from type I SMA fetuses, including skeletal muscles and, as previously shown, spinal cord. While our data do not help decide whether SMA results from impaired SMN expression in spinal cord, skeletal muscle or both, they suggest a requirement for SMN protein during embryo-fetal development.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811937     DOI: 10.1093/hmg/7.12.1927

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  38 in total

Review 1.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

3.  The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy.

Authors:  Constantin d'Ydewalle; Daniel M Ramos; Noah J Pyles; Shi-Yan Ng; Mariusz Gorz; Celeste M Pilato; Karen Ling; Lingling Kong; Amanda J Ward; Lee L Rubin; Frank Rigo; C Frank Bennett; Charlotte J Sumner
Journal:  Neuron       Date:  2016-12-22       Impact factor: 17.173

Review 4.  Advances in therapy for spinal muscular atrophy: promises and challenges.

Authors:  Ewout J N Groen; Kevin Talbot; Thomas H Gillingwater
Journal:  Nat Rev Neurol       Date:  2018-02-09       Impact factor: 42.937

Review 5.  Diverse role of survival motor neuron protein.

Authors:  Ravindra N Singh; Matthew D Howell; Eric W Ottesen; Natalia N Singh
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-15       Impact factor: 4.490

6.  Reorganization of the nuclear compartments involved in transcription and RNA processing in myonuclei of type I spinal muscular atrophy.

Authors:  María S Castillo-Iglesias; María T Berciano; J Oriol Narcis; J Fernando Val-Bernal; José C Rodriguez-Rey; Olga Tapia; Miguel Lafarga
Journal:  Histochem Cell Biol       Date:  2019-06-11       Impact factor: 4.304

7.  SMN deficiency reduces cellular ability to form stress granules, sensitizing cells to stress.

Authors:  Tie Zou; Xianming Yang; Danmin Pan; Jia Huang; Mustafa Sahin; Jianhua Zhou
Journal:  Cell Mol Neurobiol       Date:  2011-01-15       Impact factor: 5.046

8.  DNA Damage Response and DNA Repair in Skeletal Myocytes From a Mouse Model of Spinal Muscular Atrophy.

Authors:  Saniya Fayzullina; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-24       Impact factor: 3.685

Review 9.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610

10.  Behavioral and electrophysiological outcomes of tissue-specific Smn knockdown in Drosophila melanogaster.

Authors:  Christina Timmerman; Subhabrata Sanyal
Journal:  Brain Res       Date:  2012-10-26       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.